Information Provided By: 
Fly News Breaks for June 13, 2018
BIOS
Jun 13, 2018 | 08:56 EDT
BioScrip shares "are at the cusp of really working," Barrington analyst Michael Petusky tells investors in a research note. He keeps an Outperform rating on the stock with a $3.50 price target. The analyst believes much of the company's operational progress over the past couple of years "has been masked to some extent." The remainder of 2018's financial results are likely to come with less "noise" and better reflect the true operational improvements that have been executed at BioScrip over the past two years, the analyst contends.
News For BIOS From the Last 2 Days
There are no results for your query BIOS
